Catalyst Pharmaceutical Partners shares owned by Susquehanna International
Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Susquehanna International
from 13F filings
Historical chart of Susquehanna International investment in Catalyst Pharmaceutical Partners
Tip: Access up to 7 years of quarterly data
All positions including Catalyst Pharmaceutical Partners held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Catalyst Pharmaceutical Partners by Susquehanna International
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.2M | 141k | 15.94 |
2023-09-30 | $1.7M | 149k | 11.69 |
2023-06-30 | $3.6M | 264k | 13.44 |
2023-03-31 | $7.2M | 434k | 16.58 |
2022-12-31 | $9.3M | 501k | 18.60 |
2022-09-30 | $3.3M | 254k | 12.83 |
2022-06-30 | $418k | 60k | 7.01 |
2022-03-31 | $924k | 112k | 8.29 |
2021-12-31 | $1.1M | 168k | 6.77 |
2021-09-30 | $1.2M | 233k | 5.29 |
2021-06-30 | $3.0M | 521k | 5.75 |
2021-03-31 | $919k | 199k | 4.61 |
2020-12-31 | $505k | 152k | 3.34 |
2020-09-30 | $847k | 286k | 2.96 |
2020-06-30 | $663k | 144k | 4.62 |
2020-03-31 | $1.0M | 272k | 3.85 |
2019-12-31 | $781k | 208k | 3.75 |
2019-09-30 | $2.2M | 420k | 5.31 |
2019-06-30 | $2.2M | 573k | 3.88 |
2019-03-31 | $1.1M | 206k | 5.10 |
2018-12-31 | $119k | 62k | 1.91 |
2018-09-30 | $995k | 263k | 3.78 |
2018-06-30 | $300k | 95k | 3.15 |
2018-03-31 | $126k | 53k | 2.39 |
2017-12-31 | $299k | 76k | 3.92 |
2017-09-30 | $98k | 39k | 2.55 |
2017-06-30 | $405k | 148k | 2.73 |
2016-12-31 | $63k | 60k | 1.06 |
2016-09-30 | $88k | 81k | 1.09 |
2016-06-30 | $80k | 112k | 0.71 |
2016-03-31 | $38k | 32k | 1.19 |
2015-12-31 | $63k | 26k | 2.44 |
2015-09-30 | $71k | 24k | 3.02 |
2015-06-30 | $400k | 97k | 4.14 |
2015-03-31 | $1.6M | 359k | 4.33 |
2014-12-31 | $199k | 67k | 2.98 |
2014-09-30 | $218k | 66k | 3.33 |
2014-06-30 | $347k | 137k | 2.53 |
Top funds holding Catalyst Pharmaceutical Partners
View all funds holding Catalyst Pharmaceutical Partners